针对骨髓瘤的CAR-T细胞疗法的现状和未来挑战
Shizhe Li1,2, He Zhang1, Guanning Shang1
1Department of Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in immunology
|January 8, 2024
概括
化学抗原受体 (CAR) -T细胞疗法对骨髓瘤,一种具有挑战性的骨癌,显示出前景. 克服固体瘤的局限性是改善这种儿科恶性瘤治疗的关键.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 骨肉瘤是儿童和青少年最常见的骨癌,转移性或复发性病例的预后不佳.
- 目前的手术和化疗等治疗方法都有局限性,包括耐药性和不切实际的瘤切除.
- 化学抗原受体 (CAR) -T细胞疗法在血液癌症中有效,但在骨髓瘤等固体瘤中面临挑战.
研究的目的:
- 审查CAR-T细胞治疗骨髓瘤的当前研究状况.
- 确定在骨髓瘤中CAR-T细胞治疗的有希望的目标和挑战.
- 建议未来的研究方向,以加强骨髓瘤治疗.
主要方法:
- 关于骨髓瘤CAR-T细胞治疗的最新科学文献的汇编和综述.
- 分析临床前研究,确定潜在的治疗点.
- 对阻碍CAR-T细胞治疗在固体瘤中的疗效的局限性的评估.
主要成果:
- 卡尔-T细胞疗法在血液性恶性瘤中取得了进展,但在骨髓瘤中面临重大障碍.
- 挑战包括低抗原特异性,有限的T细胞持久性和免疫抑制性瘤微环境.
- 一些临床前研究表明,骨髓瘤有望成为治疗点.
结论:
- CAR-T细胞疗法对骨髓瘤治疗有潜力,但进一步的研究是必不可少的.
- 解决固体瘤应用中的挑战对于临床成功至关重要.
- 未来的研究应该专注于克服瘤微环境的新目标和策略.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
532
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
